U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954090) titled 'Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study' on April 14.
Brief Summary: Title:
Body fluid proteome SIGnatures for persoNALised intervention to prevent cardiovascular and renal complications in diabetes.
Aim:
To explore the feasibility of using urinary proteomic risk scores in clinical practice to identify patients at risk of developing end organ damage and identify which patients should receive additional renocardiovascular protective treatment.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Type 2 DM
Type 2 DM /Diabetic Nephropathy
Albuminur...